Quarterly Activities/Appendix 4C Cash Flow Report

Open PDF
Stock Mpower Group Ltd (MPR.ASX)
Release Time 30 Apr 2026, 8:18 a.m.
Price Sensitive Yes
 MPower Group Ltd Quarterly Activities/Appendix 4C Cash Flow Report
Key Points
  • Sale of main undertaking for $19 million completed in September 2025
  • $1.28 million of $2 million deferred consideration received, balance pending resolution of claim
  • Exploring options including returning capital, acquiring new business, or combination of both
Full Summary

MPower Group Ltd (ASX: MPR) provided a quarterly update, reporting that the company had no substantive operating activities during the quarter following the sale of its main undertaking for a total cash consideration of approximately $19 million on 9 September 2025. The warranty claim period in respect of the sale transaction expired on 9 March 2026, and the company received payment of $1.28 million of the $2.0 million deferred consideration on 9 March 2026. The balance of $0.72 million has been held by the buyer pursuant to a claim under an indemnity provided by the company in respect of the Lakeland solar farm, which was one of the assets sold. The company and the buyer are in discussions to resolve the claim, and the company will update shareholders with any developments. Separately, a subsidiary of the company has received a 'Direction to rectify' under an Engineering, Procurement and Construction contract completed in 2024 in respect of a NSW renewable energy project, which is currently being reviewed. Outside of those legacy items, the company continues the process of determining its options, which include returning capital to shareholders to enable them to liquidate their investments, acquiring a new business through a backdoor listing transaction, or a combination of the two. The board is actively seeking an opportunity that meets its criteria relating to size, delivering value over and above cash value to the MPR shareholders, being appropriate for a listed company, and having promising commercial prospects.